FDAJanuary 30, 2017drug

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

What to do

FDA enforcement status: Terminated

Brands named

actavis

UPCs

305910900304

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →